In addition, pectic-type polysaccharides such as rhamnogalacturonan-I (RG-I) and homogalacturonan (HG) have demonstrated potential in addressing metabolic disorders, including insulin resistance, inflammation, and diet-induced obesity [42]. This evidence concerns the gene INS and metabolic disease.